Motif ID: Tfdp1_Wt1_Egr2
Z-value: 1.745
Transcription factors associated with Tfdp1_Wt1_Egr2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Egr2 | ENSMUSG00000037868.9 | Egr2 |
| Tfdp1 | ENSMUSG00000038482.10 | Tfdp1 |
| Wt1 | ENSMUSG00000016458.7 | Wt1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tfdp1 | mm10_v2_chr8_+_13339656_13339674 | 0.42 | 1.0e-02 | Click! |
| Egr2 | mm10_v2_chr10_+_67537861_67537930 | -0.15 | 3.8e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 10.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 3.1 | 3.1 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 2.9 | 11.6 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
| 2.8 | 8.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 2.7 | 10.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 2.6 | 7.8 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 2.6 | 5.2 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.5 | 9.8 | GO:0003360 | brainstem development(GO:0003360) |
| 2.4 | 9.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.2 | 8.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 2.0 | 13.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 | 11.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 1.9 | 3.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.9 | 5.7 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 1.9 | 7.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 1.8 | 9.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 1.8 | 7.2 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
| 1.8 | 5.3 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.7 | 5.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.7 | 3.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.7 | 8.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 1.7 | 1.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
| 1.6 | 4.8 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 1.6 | 3.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 1.5 | 4.6 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.5 | 16.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.5 | 10.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.5 | 14.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 1.5 | 1.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 1.5 | 4.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.5 | 4.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 1.4 | 2.8 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 1.4 | 4.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.3 | 4.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.3 | 4.0 | GO:0060023 | soft palate development(GO:0060023) |
| 1.3 | 5.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 1.3 | 1.3 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.3 | 3.8 | GO:1900133 | renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 1.2 | 7.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.2 | 5.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.2 | 7.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.2 | 4.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.2 | 3.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 1.2 | 8.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
| 1.2 | 8.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.2 | 10.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 1.1 | 3.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 1.1 | 3.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 1.1 | 7.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 1.1 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.1 | 6.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 1.1 | 15.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.1 | 3.3 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.1 | 2.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.1 | 3.3 | GO:0060853 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.1 | 4.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.1 | 12.0 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 1.1 | 7.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.1 | 15.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 1.1 | 5.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 | 3.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.1 | 10.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.1 | 3.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.1 | 7.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.0 | 10.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.0 | 3.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.0 | 5.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 1.0 | 1.0 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 1.0 | 3.1 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.0 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.0 | 4.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 1.0 | 3.0 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.0 | 3.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.0 | 4.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 1.0 | 2.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.0 | 2.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.9 | 8.5 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.9 | 2.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.9 | 1.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.9 | 6.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.9 | 1.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.9 | 1.8 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.9 | 6.5 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.9 | 3.7 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.9 | 2.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.9 | 2.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.9 | 2.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.9 | 1.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.9 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.9 | 3.4 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.9 | 2.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.8 | 3.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.8 | 2.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.8 | 2.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 | 1.6 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.8 | 6.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.8 | 2.4 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.8 | 4.6 | GO:0032796 | uropod organization(GO:0032796) |
| 0.8 | 3.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.8 | 3.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.8 | 3.0 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.7 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.7 | 3.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 | 2.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.7 | 0.7 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.7 | 5.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.7 | 1.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
| 0.7 | 0.7 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 0.7 | 5.8 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.7 | 10.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.7 | 3.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.7 | 5.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.7 | 3.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.7 | 2.1 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.7 | 2.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.7 | 2.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.7 | 2.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.7 | 3.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 | 2.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.7 | 2.1 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.7 | 0.7 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.7 | 7.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.7 | 2.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
| 0.7 | 2.7 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 | 2.0 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.7 | 1.4 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.7 | 2.0 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.7 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 | 2.0 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 | 4.0 | GO:0032439 | endosome localization(GO:0032439) |
| 0.7 | 1.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.7 | 0.7 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.7 | 2.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.7 | 2.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.7 | 3.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.7 | 0.7 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.6 | 1.9 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.6 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.6 | 1.9 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.6 | 1.9 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.6 | 1.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.6 | 1.9 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.6 | 1.9 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.6 | 5.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.6 | 0.6 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.6 | 3.1 | GO:0031424 | keratinization(GO:0031424) |
| 0.6 | 4.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.6 | 3.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.6 | 2.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.6 | 2.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 0.6 | 14.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 | 3.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.6 | 6.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.6 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
| 0.6 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.6 | 1.8 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.6 | 1.8 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.6 | 14.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.6 | 1.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.6 | 1.8 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 1.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.6 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.6 | 3.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.6 | 7.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.6 | 1.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.6 | 1.7 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.6 | 2.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.6 | 1.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.6 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 | 3.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.6 | 2.2 | GO:0045924 | regulation of female receptivity(GO:0045924) |
| 0.6 | 0.6 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.6 | 0.6 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.5 | 2.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.5 | 2.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.5 | 6.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.5 | 1.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 | 5.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 | 2.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.5 | 3.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.5 | 1.6 | GO:0030070 | insulin processing(GO:0030070) |
| 0.5 | 1.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 | 1.6 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 | 3.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.5 | 2.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.5 | 8.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.5 | 3.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.5 | 1.5 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.5 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.5 | 0.5 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.5 | 1.0 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.5 | 4.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.5 | 1.9 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.5 | 1.9 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.5 | 5.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.5 | 1.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.5 | 3.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.5 | 1.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 | 1.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.5 | 1.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.5 | 1.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 1.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.5 | 1.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.5 | 0.9 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.5 | 0.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.5 | 5.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.5 | 1.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 | 7.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.5 | 2.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.5 | 7.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.4 | 1.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.4 | 1.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 | 1.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.4 | 1.3 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.4 | 1.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.4 | 2.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.4 | 0.4 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 | 1.7 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 1.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 | 6.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 1.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 0.4 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 | 1.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.4 | 1.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 | 7.2 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.4 | 0.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.4 | 1.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.4 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 2.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 | 1.2 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.4 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 2.9 | GO:0031000 | response to caffeine(GO:0031000) |
| 0.4 | 4.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 | 4.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 1.2 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.4 | 2.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.4 | 0.4 | GO:0060534 | trachea cartilage development(GO:0060534) |
| 0.4 | 1.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.4 | 2.0 | GO:2001184 | regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.4 | 2.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 | 1.6 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.4 | 2.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 | 2.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.4 | 2.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 6.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.4 | 1.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.4 | 1.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 | 1.5 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.4 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 | 1.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 | 1.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 1.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.4 | 0.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.4 | 1.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 3.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.4 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.4 | 3.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.4 | 2.2 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 0.4 | 0.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.4 | 2.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.4 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.4 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.4 | 1.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.4 | 3.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.4 | 2.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 | 1.1 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
| 0.4 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 0.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 2.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.4 | 3.5 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
| 0.4 | 1.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.4 | 4.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.4 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 | 0.7 | GO:1904207 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 | 2.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.3 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.3 | 4.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.3 | 5.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 6.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 | 0.7 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 0.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 1.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 | 0.7 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.3 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 | 0.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 0.3 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) gamma-delta T cell activation(GO:0046629) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 | 3.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.3 | 1.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 0.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.3 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 | 4.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.3 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.3 | 2.3 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.3 | 1.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
| 0.3 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.3 | 3.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 2.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 | 0.3 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
| 0.3 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 0.3 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.3 | 0.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.3 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.3 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.3 | 0.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 | 1.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 0.9 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 2.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.3 | 0.9 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.3 | 1.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 0.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.3 | 3.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.3 | 1.8 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
| 0.3 | 2.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.3 | 0.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.3 | 2.4 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.3 | 1.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 1.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.3 | 0.9 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.3 | 1.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.3 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.3 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.3 | 0.3 | GO:0099548 | trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
| 0.3 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 3.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 2.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.3 | 1.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.3 | 0.8 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 | 2.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.3 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.3 | 0.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.3 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.3 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.3 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.3 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.3 | 3.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 1.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 | 1.1 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.3 | 0.8 | GO:0045004 | DNA replication proofreading(GO:0045004) |
| 0.3 | 3.9 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 | 1.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 | 0.3 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
| 0.3 | 0.8 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 | 1.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.3 | 1.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.3 | 5.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.3 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 | 0.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 | 2.4 | GO:0006415 | translational termination(GO:0006415) |
| 0.3 | 1.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.3 | 2.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.3 | 1.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.3 | 0.8 | GO:0086067 | AV node cell to bundle of His cell communication(GO:0086067) |
| 0.3 | 1.1 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 0.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 | 1.3 | GO:0048840 | otolith development(GO:0048840) |
| 0.3 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 | 2.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.3 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.3 | 4.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.3 | 2.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.3 | 0.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.3 | 0.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.3 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.3 | 6.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 1.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
| 0.2 | 1.5 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 2.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 0.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.2 | 1.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 9.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.2 | 0.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 2.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.2 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 | 2.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 0.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 | 1.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 | 1.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 2.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.2 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 | 1.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.2 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 | 1.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.2 | 1.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
| 0.2 | 2.1 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 4.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 | 0.9 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.2 | 1.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.2 | 1.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 4.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 1.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 | 1.6 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.2 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 | 2.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.2 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.2 | 1.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.2 | 0.2 | GO:0003129 | heart induction(GO:0003129) |
| 0.2 | 0.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
| 0.2 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.2 | 2.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 | 0.2 | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.2 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.2 | 0.7 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 | 1.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 0.9 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.2 | 0.2 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.2 | 1.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 0.8 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 2.7 | GO:0007530 | sex determination(GO:0007530) |
| 0.2 | 0.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 1.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 0.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 1.2 | GO:0015791 | polyol transport(GO:0015791) |
| 0.2 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 1.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.2 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 0.6 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 | 1.0 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 | 0.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.2 | 0.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 1.4 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.2 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 | 4.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.2 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.2 | 1.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 | 0.6 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 | 0.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 | 0.2 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) |
| 0.2 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 1.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 | 1.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.2 | 0.6 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.2 | 0.4 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.2 | 2.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 | 0.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.2 | 1.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.2 | 0.8 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 1.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.2 | 1.9 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.2 | 4.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.2 | 0.6 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 | 2.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.2 | 18.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.2 | 0.7 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.2 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.2 | 1.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 0.5 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.2 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 1.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.2 | 1.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 1.2 | GO:0050716 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 | 2.6 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.2 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.2 | 0.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.2 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.2 | 0.5 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.2 | 1.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.2 | 0.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.2 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 0.7 | GO:2000173 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 0.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.2 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 0.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.2 | 0.3 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
| 0.2 | 0.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.2 | 3.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.2 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 2.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 1.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 | 2.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 0.5 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.2 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 3.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 0.2 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.2 | 2.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
| 0.2 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 1.0 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.2 | 11.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.2 | 1.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.2 | 0.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 0.3 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
| 0.2 | 1.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 1.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 5.1 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.2 | 0.5 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.2 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 0.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 0.2 | 0.8 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.2 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.2 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.2 | 1.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.2 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 1.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 0.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.2 | 1.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.2 | 0.2 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.2 | 0.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.2 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.2 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.5 | GO:0018377 | N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.2 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 | 1.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.1 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.1 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 4.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 | 4.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 0.3 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.1 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.1 | 1.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.1 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 1.3 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 19.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 1.0 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 3.7 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.1 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 | 0.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.1 | 1.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 1.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.1 | 2.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.1 | 0.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 2.3 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.8 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 2.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 | 1.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 4.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.5 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 1.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.8 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.1 | 0.1 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.1 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 0.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 5.7 | GO:0070613 | regulation of protein processing(GO:0070613) |
| 0.1 | 0.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
| 0.1 | 0.8 | GO:0045061 | thymic T cell selection(GO:0045061) |
| 0.1 | 1.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
| 0.1 | 0.5 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 1.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 1.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.1 | 4.0 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.1 | 1.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 1.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.1 | 0.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.1 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.5 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.1 | 2.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
| 0.1 | 1.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.1 | 3.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.6 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.1 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
| 0.1 | 1.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 | 0.7 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.8 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 0.2 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 1.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 1.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 2.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 1.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 | 0.3 | GO:0071476 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 4.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 1.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
| 0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 | 0.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 1.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 1.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 | 2.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 | 4.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 | 0.4 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 | 0.6 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.1 | 0.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.1 | 0.7 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.1 | 0.1 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 | 0.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.1 | 4.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.1 | 0.5 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.4 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 0.1 | GO:0060384 | innervation(GO:0060384) |
| 0.1 | 0.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.1 | 1.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
| 0.1 | 1.9 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 2.5 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
| 0.1 | 0.3 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.1 | 0.8 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.1 | 0.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.3 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.1 | GO:1903317 | regulation of protein maturation(GO:1903317) |
| 0.1 | 1.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.1 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 0.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 2.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 1.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.1 | 0.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.1 | 0.2 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 1.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.9 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 | 1.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.1 | 0.2 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 0.4 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
| 0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 0.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.1 | 0.2 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.1 | 0.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.4 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.8 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
| 0.1 | 1.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.1 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
| 0.1 | 0.8 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
| 0.1 | 2.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
| 0.1 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 0.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 | 2.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.3 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.9 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 | 1.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.4 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.1 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.1 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 0.1 | 0.4 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.1 | 1.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.1 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 | 1.4 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.1 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.3 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 | 0.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 0.2 | GO:0001821 | histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 0.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
| 0.1 | 2.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.1 | 0.3 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.1 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 | 0.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.3 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.1 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
| 0.1 | 0.2 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
| 0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.1 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.4 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 | 0.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 0.0 | GO:0051653 | spindle localization(GO:0051653) |
| 0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.0 | 0.7 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 | 4.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.0 | 0.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.0 | 1.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.0 | 0.2 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.0 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.0 | 0.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.1 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 0.2 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 | 0.6 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.0 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 1.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
| 0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.1 | GO:0099637 | neurotransmitter receptor transport(GO:0099637) |
| 0.0 | 0.1 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.0 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.0 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 | 0.3 | GO:0010878 | cholesterol storage(GO:0010878) |
| 0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.0 | 0.0 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.0 | 0.3 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
| 0.0 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.0 | 0.1 | GO:0048631 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 | 0.1 | GO:1901621 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 | 0.2 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.0 | 0.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.0 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.8 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 1.4 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.0 | 0.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.8 | GO:0060711 | labyrinthine layer development(GO:0060711) |
| 0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 | 0.0 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.0 | 0.1 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
| 0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.0 | 0.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 0.0 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 | 0.1 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.0 | 0.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 0.2 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.0 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.0 | 0.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.0 | 0.0 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.0 | 0.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.0 | 0.0 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.0 | 0.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.0 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 | 0.0 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
| 0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
| 0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.0 | 0.0 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 9.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 2.4 | 7.2 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
| 2.0 | 6.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.6 | 4.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 1.4 | 5.7 | GO:0060187 | cell pole(GO:0060187) |
| 1.3 | 20.7 | GO:0043196 | varicosity(GO:0043196) |
| 1.2 | 5.0 | GO:0090537 | CERF complex(GO:0090537) |
| 1.2 | 1.2 | GO:0034704 | calcium channel complex(GO:0034704) |
| 1.1 | 3.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.0 | 4.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 1.0 | 18.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 5.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.9 | 3.5 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.8 | 14.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.8 | 4.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.8 | 2.4 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 0.8 | 11.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.8 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.7 | 4.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.7 | 2.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.7 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.6 | 4.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.6 | 2.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.6 | 3.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.6 | 3.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.6 | 24.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.6 | 0.6 | GO:0097433 | dense body(GO:0097433) |
| 0.6 | 3.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.6 | 1.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.6 | 2.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.6 | 3.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.6 | 14.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.6 | 2.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.6 | 16.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.6 | 1.7 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 0.6 | 20.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.6 | 2.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.6 | 6.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.6 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.6 | 11.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.5 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.5 | 5.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.5 | 2.6 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.5 | 6.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 1.5 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.5 | 1.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.5 | 3.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.5 | 3.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.5 | 4.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.4 | 5.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.4 | 2.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.4 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.4 | 2.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.4 | 4.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.4 | 3.2 | GO:0005883 | neurofilament(GO:0005883) |
| 0.4 | 1.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.4 | 1.2 | GO:0002141 | stereocilia ankle link(GO:0002141) |
| 0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.4 | 4.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 1.1 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.4 | 3.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.4 | 1.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.4 | 4.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 2.8 | GO:0070938 | contractile ring(GO:0070938) |
| 0.4 | 2.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.4 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 14.7 | GO:0002102 | podosome(GO:0002102) |
| 0.3 | 1.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 4.5 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 4.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.3 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.3 | 5.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 2.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.3 | 3.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 21.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.3 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 2.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.3 | 7.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 1.3 | GO:0008623 | CHRAC(GO:0008623) |
| 0.3 | 4.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.3 | 1.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 1.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.3 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
| 0.3 | 1.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.3 | 3.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.3 | 1.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.3 | 11.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.3 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.3 | 0.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 4.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.3 | 15.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 0.3 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.3 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.3 | 8.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 2.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 8.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.3 | 3.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 1.3 | GO:0000235 | astral microtubule(GO:0000235) |
| 0.3 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.3 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.3 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 6.1 | GO:0001741 | XY body(GO:0001741) |
| 0.3 | 2.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.3 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.3 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 0.3 | 1.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 4.6 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 1.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 4.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.2 | 1.7 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 1.7 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 2.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 8.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 1.7 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 2.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 3.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 8.0 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 1.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 3.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 4.5 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 4.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 0.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.2 | 3.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 5.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 1.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.2 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 14.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 3.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 0.6 | GO:0043512 | inhibin A complex(GO:0043512) |
| 0.2 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.2 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 0.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.2 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 15.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 0.6 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 0.2 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.2 | 5.3 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 1.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 0.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.2 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.2 | 0.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.2 | 2.8 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 2.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 2.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.2 | 2.3 | GO:0031105 | septin complex(GO:0031105) |
| 0.2 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 0.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 0.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 11.6 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.2 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 5.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 3.8 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 7.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.2 | 1.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 1.6 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 3.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 0.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 1.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 1.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 4.9 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 2.0 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 2.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 1.7 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 1.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 1.8 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 3.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 2.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 6.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 1.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.4 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.1 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 2.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 9.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 5.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 3.3 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 5.2 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.1 | 23.0 | GO:0098794 | postsynapse(GO:0098794) |
| 0.1 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 1.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 25.0 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.1 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 0.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 3.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 12.6 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 2.8 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 7.7 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 7.3 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 4.6 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 3.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 0.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.1 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 3.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 2.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 7.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.1 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.1 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 0.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 0.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 5.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 0.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
| 0.1 | 2.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 1.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 0.2 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 3.0 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.7 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.2 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.1 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 5.4 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 2.4 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 0.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 0.1 | GO:0042995 | cell projection(GO:0042995) |
| 0.1 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.8 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 1.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 3.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 1.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 0.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.0 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 2.1 | GO:0000776 | kinetochore(GO:0000776) |
| 0.0 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.0 | 2.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.7 | GO:0005929 | cilium(GO:0005929) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
| 0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 1.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 2.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.1 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.5 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 0.0 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 0.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.0 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.0 | 0.6 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 3.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 3.2 | 15.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 2.9 | 11.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 2.7 | 8.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 2.7 | 10.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 2.7 | 8.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 2.5 | 14.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 2.3 | 7.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 1.8 | 11.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 1.7 | 13.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.7 | 5.2 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.6 | 12.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.5 | 6.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.5 | 4.4 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 1.3 | 4.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.3 | 5.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.3 | 4.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.3 | 5.0 | GO:0070976 | TIR domain binding(GO:0070976) |
| 1.3 | 3.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.2 | 9.9 | GO:0046790 | virion binding(GO:0046790) |
| 1.2 | 7.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.2 | 16.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.2 | 3.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.1 | 3.4 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 1.1 | 3.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 1.1 | 3.4 | GO:0051379 | epinephrine binding(GO:0051379) |
| 1.1 | 7.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 1.1 | 3.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.1 | 6.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 1.1 | 12.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.1 | 7.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 1.1 | 3.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 1.1 | 16.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 1.0 | 4.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 1.0 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 1.0 | 7.0 | GO:0048185 | activin binding(GO:0048185) |
| 1.0 | 12.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.0 | 15.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.9 | 7.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.9 | 4.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.9 | 7.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.9 | 2.7 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.9 | 2.7 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 0.9 | 5.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.9 | 5.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.8 | 6.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.8 | 4.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.8 | 2.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.8 | 2.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.8 | 22.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.7 | 2.1 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.7 | 4.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.7 | 0.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.7 | 2.0 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.7 | 2.0 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 0.7 | 2.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.7 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.7 | 3.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.7 | 5.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.6 | 5.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.6 | 7.0 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 3.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.6 | 6.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.6 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 3.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.6 | 14.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.6 | 1.7 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
| 0.6 | 2.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.6 | 2.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.5 | 2.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.5 | 4.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.5 | 8.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.5 | 19.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.5 | 0.5 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
| 0.5 | 3.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.5 | 5.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.5 | 2.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.5 | 5.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.5 | 18.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.5 | 3.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.5 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.5 | 4.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.5 | 18.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.5 | 3.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.5 | 3.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.5 | 3.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.5 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.5 | 2.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.5 | 2.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.5 | 1.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.5 | 1.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.5 | 9.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.5 | 14.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.5 | 4.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.5 | 1.4 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.5 | 4.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.5 | 3.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.5 | 1.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.5 | 1.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.5 | 2.7 | GO:0019841 | retinol binding(GO:0019841) |
| 0.4 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.4 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 5.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.4 | 2.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.4 | 0.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.4 | 2.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.4 | 0.4 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 4.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 7.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 1.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 10.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.4 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.4 | 3.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.4 | 2.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.4 | 1.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 1.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.4 | 2.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.4 | 5.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.4 | 2.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.4 | 2.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 6.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.4 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.4 | 2.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.4 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.3 | 5.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.3 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 3.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 3.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 1.0 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.3 | 1.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.3 | 1.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 1.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.0 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.3 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 1.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.3 | 1.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.3 | 1.0 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.3 | 1.0 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
| 0.3 | 3.5 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.3 | 5.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.3 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.3 | 1.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.3 | 1.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 1.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.3 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 1.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 1.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 1.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.3 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 0.6 | GO:0032564 | dATP binding(GO:0032564) |
| 0.3 | 1.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.3 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 1.8 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.3 | 0.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.3 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.3 | 6.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.3 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 2.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.3 | 1.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.3 | 5.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 0.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.3 | 2.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.3 | 1.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.3 | 2.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 3.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.3 | 2.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.3 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
| 0.3 | 1.5 | GO:0045340 | mercury ion binding(GO:0045340) |
| 0.3 | 3.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 1.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.3 | 0.8 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.3 | 0.8 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.3 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 1.0 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.2 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 1.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 17.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.2 | 2.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.2 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.2 | 1.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 6.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.2 | 2.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 3.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 0.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 0.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 2.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.2 | 1.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 3.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 2.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.2 | 2.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 0.7 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 3.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 0.7 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 0.2 | 5.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 8.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 4.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 2.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.2 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 6.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 6.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 1.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 7.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 3.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 0.6 | GO:0004532 | exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 4.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 0.6 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.2 | 3.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.2 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.2 | 0.6 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.2 | 0.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.2 | 0.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 1.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 0.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.2 | 1.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.2 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 0.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 3.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 13.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 0.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 0.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.2 | 1.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.2 | 0.5 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.2 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 5.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.2 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 0.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.2 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 2.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.2 | 0.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.2 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.2 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 2.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.2 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 2.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 2.9 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 0.6 | GO:0070279 | vitamin B6 binding(GO:0070279) |
| 0.2 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 1.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.2 | 0.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.1 | 1.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 2.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 3.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 37.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 5.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 0.3 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.1 | 0.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.1 | 2.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.4 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.1 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 0.8 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 2.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 0.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 2.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 1.1 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.1 | 2.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.1 | 0.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 3.6 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
| 0.1 | 0.3 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.1 | 1.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.1 | 0.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 4.7 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.1 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 2.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 9.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 1.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 16.8 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 3.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 7.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 0.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.1 | 0.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 2.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
| 0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.1 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.4 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.1 | 0.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.1 | 2.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 0.3 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 2.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 1.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.1 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.1 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 3.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 0.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) |
| 0.1 | 3.0 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.3 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
| 0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 1.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.1 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 0.2 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
| 0.1 | 0.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
| 0.1 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.7 | GO:0016874 | ligase activity(GO:0016874) |
| 0.1 | 0.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.1 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
| 0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 2.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.1 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
| 0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.0 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
| 0.0 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.0 | 0.1 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
| 0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
| 0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 0.5 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.0 | 0.5 | GO:0005496 | steroid binding(GO:0005496) |
| 0.0 | 0.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 2.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.0 | 0.2 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.0 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.0 | 0.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
| 0.0 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 7.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 1.6 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 1.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 4.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.0 | 0.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 0.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.0 | 0.6 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.1 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.0 | 1.6 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
| 0.0 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.0 | GO:0005536 | glucose binding(GO:0005536) |
| 0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.0 | 1.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 0.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.0 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 0.0 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.0 | 0.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 1.4 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 1.1 | 19.3 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.6 | 0.6 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.6 | 5.4 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.6 | 2.4 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.6 | 1.7 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.5 | 5.8 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.5 | 18.0 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.4 | 20.0 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.4 | 18.2 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.4 | 27.3 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.4 | 6.1 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 13.4 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.4 | 0.4 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.4 | 14.3 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 0.7 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.4 | 10.3 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.4 | 3.5 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 12.8 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 4.1 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.3 | 0.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.3 | 3.0 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 5.7 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.2 | 4.2 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.2 | 5.2 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 11.3 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 1.3 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.2 | 0.4 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.2 | 3.9 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 6.2 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 14.5 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 1.0 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 1.7 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 1.3 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.2 | 10.0 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.2 | 4.8 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
| 0.2 | 3.5 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 7.6 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 0.5 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.2 | 1.2 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 7.6 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.2 | 2.7 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.2 | 3.1 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 0.6 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 1.6 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.2 | 0.5 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 0.2 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.2 | 2.6 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
| 0.2 | 3.4 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.1 | 5.5 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
| 0.1 | 15.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 0.4 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.1 | 5.4 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.1 | 8.1 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.1 | 2.0 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 0.1 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 3.3 | PID_ATM_PATHWAY | ATM pathway |
| 0.1 | 1.5 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.1 | 0.2 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 9.1 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 6.2 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.1 | 1.4 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.3 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 3.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 2.1 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.2 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 0.4 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 1.6 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.1 | 2.4 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.1 | 4.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.6 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.2 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 3.0 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.1 | 1.4 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.8 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 8.3 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 0.7 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 0.9 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.5 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.1 | ST_GA13_PATHWAY | G alpha 13 Pathway |
| 0.0 | 1.0 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.6 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.5 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.1 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.1 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.3 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.2 | ST_GAQ_PATHWAY | G alpha q Pathway |
| 0.0 | 0.7 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.1 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 1.3 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 1.0 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.8 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.5 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 1.0 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.0 | 0.5 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.2 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.0 | 0.5 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.1 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.4 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.2 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.4 | PID_AURORA_B_PATHWAY | Aurora B signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 19.2 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 1.1 | 10.3 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 1.0 | 2.9 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.8 | 14.8 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.8 | 10.7 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.8 | 15.9 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.7 | 10.5 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.7 | 29.0 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.7 | 25.5 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.6 | 5.5 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.6 | 13.2 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.6 | 11.1 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.6 | 11.6 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.5 | 5.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.5 | 13.2 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.5 | 4.0 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.5 | 0.5 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.5 | 1.5 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.5 | 11.9 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.5 | 0.5 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.5 | 3.3 | REACTOME_SIGNALING_BY_NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.4 | 12.3 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 0.4 | 6.8 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 6.7 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.4 | 5.5 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.4 | 3.7 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.4 | 11.9 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.4 | 1.1 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.3 | 9.8 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 0.3 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.3 | 6.3 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.3 | 5.9 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 12.1 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.3 | 6.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 4.8 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 3.9 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 5.7 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.3 | 9.1 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.3 | 3.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 3.6 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
| 0.3 | 8.8 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.3 | 2.1 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 4.4 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.3 | 15.6 | REACTOME_SIGNALING_BY_NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.3 | 5.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 2.2 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 0.5 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 5.5 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 3.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 1.3 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 7.6 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 5.1 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 1.8 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 0.6 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 1.5 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 0.8 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 5.6 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 4.3 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.2 | 8.8 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.2 | 9.9 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 0.4 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 1.7 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 1.2 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.2 | 0.4 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 3.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 0.2 | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | Genes involved in Phosphorylation of the APC/C |
| 0.2 | 8.1 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 0.8 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 1.4 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.2 | 1.9 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 1.9 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 1.7 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 1.2 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 11.7 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 3.9 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.6 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 1.1 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 3.1 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 5.2 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 1.1 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 1.2 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 5.4 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 3.5 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 0.4 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.1 | 0.4 | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.1 | 2.2 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 0.7 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.7 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 0.4 | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | Genes involved in Orc1 removal from chromatin |
| 0.1 | 1.9 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.8 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 0.5 | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 0.8 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.5 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 0.9 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 0.9 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 0.3 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.1 | 1.4 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.1 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 1.2 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 0.2 | REACTOME_G1_S_TRANSITION | Genes involved in G1/S Transition |
| 0.1 | 2.2 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 2.3 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 1.1 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 6.5 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 1.5 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.3 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 0.2 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 0.4 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 7.7 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 9.0 | REACTOME_DIABETES_PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 0.6 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.1 | 0.5 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 1.0 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 0.8 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
| 0.1 | 0.3 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.1 | 15.8 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.7 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 0.7 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.1 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 2.7 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.9 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.1 | 0.1 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 0.1 | REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.1 | 1.6 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 1.8 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.5 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 0.3 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.1 | 0.7 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.4 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 1.5 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.4 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 0.1 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 0.5 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 9.1 | REACTOME_MRNA_PROCESSING | Genes involved in mRNA Processing |
| 0.1 | 0.9 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.7 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 1.2 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 0.3 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.5 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.1 | 0.2 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 0.8 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 0.8 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 0.0 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.0 | 0.4 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.3 | REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 0.3 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 1.5 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 3.5 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.2 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.1 | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.0 | 0.3 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.9 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.1 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.3 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 0.1 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 1.2 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.5 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.9 | REACTOME_METABOLISM_OF_NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.0 | 0.3 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 0.5 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.1 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 0.1 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.1 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 0.1 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
|
|
|